Harrow Health, Inc.
NASDAQ:HROW
Overview | Financials
Company Name | Harrow Health, Inc. |
Symbol | HROW |
Currency | USD |
Price | 35.4 |
Market Cap | 1,260,760,380 |
Dividend Yield | 0% |
52-week-range | 9.13 - 59.23 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Mark L. Baum J.D. |
Website | https://www.harrowinc.com |
An error occurred while fetching data.
About Harrow Health, Inc.
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD